SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-05-138175
Filing Date
2005-07-06
Accepted
2005-07-06 17:24:44
Documents
2
Period of Report
2005-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K d8ka.htm 8-K/A 20681
2 DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENT dex101.htm EX-10.1 491402
  Complete submission text file 0001193125-05-138175.txt   513700
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-26727 | Film No.: 05941625
SIC: 2834 Pharmaceutical Preparations